title: Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation.
authors.forename: S-H
authors.initials: SH
authors.lastname: Lee
authors.forename: B-C
authors.initials: BC
authors.lastname: Kim
authors.forename: D-H
authors.initials: DH
authors.lastname: Yang
authors.forename: M-S
authors.initials: MS
authors.lastname: Park
authors.forename: S-M
authors.initials: SM
authors.lastname: Choi
authors.forename: M-K
authors.initials: MK
authors.lastname: Kim
authors.forename: K-H
authors.initials: KH
authors.lastname: Cho
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods; D001925:Brain Damage, Chronic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D019703:Calcineurin / Q000378:metabolism; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006624:Hippocampus / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008569:Memory Disorders / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D009483:Neuropsychological Tests; D020258:Neurotoxicity Syndromes / Q000175:diagnosis; D016559:Tacrolimus / Q000009:adverse effects
chemical_list: D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus